Anti-fibroblast growth factor-8 monoclonal antibody
AssigneeKyowa Hakko Kogyo Co., Ltd.
InventorsNobuo Hanai, Motoo Yamasaki, Akiko Furuya, Akira Tanaka
Life of this patent
Estimating the term…
Abstract
Described is a monoclonal antibody capable of specifically binding to fibroblast growth factor-8 (FGF-8) which is related to growth factors of hormone-dependent tumor cells such as prostatic cancer and breast cancer, and inhibits the FGF-8 activity. The monoclonal antibody is useful in analyzing the role and biological function of FGF-8 in hormone-dependent tumor cells such as prostatic cancer and breast cancer and can be beneficial in the treatment of these cancers.
Claims4
A pharmaceutical composition comprising a monoclonal antibody which specifically binds to SEQ ID NO:1, found in the N terminal region of human fibroblast growth factor-8, and which inhibits activity of fibroblast growth factor-8 and a pharmaceutically acceptable carrier.
A composition comprising a monoclonal antibody which specifically binds to SEQ ID NO:1, found in the N terminal region of human fibroblast growth factor-8, and which inhibits activity of fibroblast growth factor-8 and an carrier.
Dependencies are inferred from the claim text.